Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Cytori to Webcast First Quarter Financial Results on May 9



  Cytori to Webcast First Quarter Financial Results on May 9

Business Wire

SAN DIEGO -- May 02, 2013

Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its first
quarter financial results and business update on Thursday, May 9, 2013 at 5:00
PM Eastern Time.

The dial-in information is as follows:

Dial-In Number: +1.877.402.3914
Conference ID: 51847937

Prior to the webcast at approximately 4:05 PM Eastern Time on May 9, Cytori
will issue its first quarter earnings release which will review Cytori's first
quarter performance. The webcast will be available both live and by replay two
hours after the call under “Webcasts” on the Company's Investor Relations
website (http://ir.cytori.com).

About Cytori

Cytori Therapeutics is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and
repair soft tissue defects. Our scientific data suggest ADRCs improve blood
flow. As a result, we believe these cells can be applied across multiple
“ischemic” conditions. These therapies are made available to the physician and
patient at the point-of-care by Cytori’s proprietary technologies and
products, including the Celution® System product family. www.cytori.com

Contact:

Cytori Therapeutics
Megan McCormick, +1-858-875-5279
mmccormick@cytori.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement